Results 311 to 320 of about 63,687 (336)
Some of the next articles are maybe not open access.
SCFAs — the thin microbial metabolic line between good and bad
Nature Reviews Endocrinology, 2019By combining genetic, metagenomic and metabolic data in humans, a recent study has identified causal relationships between the capacity of gut microorganisms to produce short-chain fatty acids, such as butyrate and propionate, and metabolic traits of the host, including insulin response during an oral glucose tolerance test and susceptibility to type 2
openaire +4 more sources
Postbiotic potential of SCFAs on metaflammation and gut microbiota alteration in diabetes
Journal of BiosciencesGut microbiota regulate host metabolism via its fermentation products, mainly short-chain fatty acids (SCFAs), i.e., acetate, propionate, and butyrate. Although butyrate is studied for its anti-inflammatory, anti-obesity, and anti-diabetic effects, propionate alone and in combination with acetate or butyrate is not well reported. In this study, we have
Dipeeka K, Mandaliya +2 more
openaire +2 more sources
SCFA Metabolism and Ischemic Colitis
Journal of Clinical Gastroenterology, 1991openaire +2 more sources
Mesophilic fermentation upgrades SCFA production from natural/raw henna plant biomass
Biomass Conversion and Biorefinery, 2020Jingang Huang +2 more
exaly
The Role of SCFAs in 5HT Mediated Colonic Motility
2017Introduction: The role of short-chain fatty acids (SCFAs) in colonic motility is controversial. Germ free (GF) mice are unable to produce SCFAs and serve as a model to study how their absence affects colonic motility. GF transit is slower than controls and colonization of these mice improves gastrointestinal (GI) transit and serotonin (5-HT) levels ...
openaire +1 more source